Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1971 1
1973 3
1974 1
1975 6
1977 2
1978 1
1979 4
1980 1
1981 5
1982 1
1983 3
1984 3
1985 4
1986 5
1987 2
1988 7
1989 2
1990 4
1991 4
1992 3
1993 5
1994 9
1995 7
1996 1
1997 7
1998 5
1999 10
2000 6
2001 5
2002 13
2003 7
2004 10
2005 6
2006 6
2007 5
2008 7
2009 10
2010 7
2011 9
2012 14
2013 23
2014 19
2015 10
2016 14
2017 7
2018 9
2019 9
2020 8
2021 9
2022 20
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

347 results

Results by year

Filters applied: . Clear all
Page 1
A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.
Zhou Y, Liu Y, Gupta S, Paramo MI, Hou Y, Mao C, Luo Y, Judd J, Wierbowski S, Bertolotti M, Nerkar M, Jehi L, Drayman N, Nicolaescu V, Gula H, Tay S, Randall G, Wang P, Lis JT, Feschotte C, Erzurum SC, Cheng F, Yu H. Zhou Y, et al. Among authors: lis jt. Nat Biotechnol. 2023 Jan;41(1):128-139. doi: 10.1038/s41587-022-01474-0. Epub 2022 Oct 10. Nat Biotechnol. 2023. PMID: 36217030 Free PMC article.
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial.
Ribas A, Puzanov I, Dummer R, Schadendorf D, Hamid O, Robert C, Hodi FS, Schachter J, Pavlick AC, Lewis KD, Cranmer LD, Blank CU, O'Day SJ, Ascierto PA, Salama AK, Margolin KA, Loquai C, Eigentler TK, Gangadhar TC, Carlino MS, Agarwala SS, Moschos SJ, Sosman JA, Goldinger SM, Shapira-Frommer R, Gonzalez R, Kirkwood JM, Wolchok JD, Eggermont A, Li XN, Zhou W, Zernhelt AM, Lis J, Ebbinghaus S, Kang SP, Daud A. Ribas A, et al. Among authors: lis j. Lancet Oncol. 2015 Aug;16(8):908-18. doi: 10.1016/S1470-2045(15)00083-2. Epub 2015 Jun 23. Lancet Oncol. 2015. PMID: 26115796 Free PMC article. Clinical Trial.
PARP goes transcription.
Kraus WL, Lis JT. Kraus WL, et al. Among authors: lis jt. Cell. 2003 Jun 13;113(6):677-83. doi: 10.1016/s0092-8674(03)00433-1. Cell. 2003. PMID: 12809599 Free article. Review.
CTCF blocks antisense transcription initiation at divergent promoters.
Luan J, Vermunt MW, Syrett CM, Coté A, Tome JM, Zhang H, Huang A, Luppino JM, Keller CA, Giardine BM, Zhang S, Dunagin MC, Zhang Z, Joyce EF, Lis JT, Raj A, Hardison RC, Blobel GA. Luan J, et al. Among authors: lis jt. Nat Struct Mol Biol. 2022 Nov;29(11):1136-1144. doi: 10.1038/s41594-022-00855-y. Epub 2022 Nov 11. Nat Struct Mol Biol. 2022. PMID: 36369346 Free PMC article.
Enhancer transcription: what, where, when, and why?
Tippens ND, Vihervaara A, Lis JT. Tippens ND, et al. Among authors: lis jt. Genes Dev. 2018 Jan 1;32(1):1-3. doi: 10.1101/gad.311605.118. Genes Dev. 2018. PMID: 29440223 Free PMC article. Review.
Nascent RNA analyses: tracking transcription and its regulation.
Wissink EM, Vihervaara A, Tippens ND, Lis JT. Wissink EM, et al. Among authors: lis jt. Nat Rev Genet. 2019 Dec;20(12):705-723. doi: 10.1038/s41576-019-0159-6. Epub 2019 Aug 9. Nat Rev Genet. 2019. PMID: 31399713 Free PMC article. Review.
347 results